Janssen Search
Search results
Partner With Our Research & Development Team
Partner With Janssen Research & Development Collaboration is in our DNA. We know where it has taken us. We know it can take us further. With a rally cry as simple as "&." Collaborations A key element of our Janssen Research & ...
Treatments for Neglected Tropical Diseases
Developing New Treatments for Neglected Tropical Diseases We Recognize the Urgent Need for Innovative Treatment Options In 2012, Johnson & Johnson signed the London Declaration on Neglected Tropical Diseases, a multilateral partnership to eliminate or ...
Calvin W. Schmidt
Calvin Schmidt is Global Commercial Strategy Leader (GCSL) for the Cardiovascular & Metabolism (CVM) therapeutic area and the GCSL for the newly created Johnson & Johnson Innovation World Without Disease Accelerator (WWDA). CVM is maximizing the ...
Ruxandra Draghia-Akli, M.D., Ph.D.
RUXANDRA DRAGHIA-AKLI, M.D., Ph.D. GLOBAL HEAD JOHNSON & JOHNSON GLOBAL PUBLIC HEALTH R&D JANSSEN RESEARCH & DEVELOPMENT Ruxandra Draghia-Akli, M.D., Ph.D., is Global Head, Johnson & Johnson Global Public Health R&D. In this role, ...
Sarah Brennan
SARAH BRENNAN COMPANY GROUP CHAIRMAN GLOBAL COMMERCIAL STRATEGY ORGANIZATION Sarah Brennan is Company Group Chairman, Global Commercial Strategy Organization, for Johnson & Johnson Innovative Medicine. In this role, Sarah will be responsible for the ...
Anthony Williamson, PH.D.
As Head of Technology at the Janssen Prevention Center, Anthony Williamson has broad responsibility for acquiring and developing innovative technologies for preventing non-communicable diseases. He brings to this role an impressive track record for ...
Paul Duncan
PAUL DUNCAN SENIOR DIRECTOR EXTERNAL INNOVATION IMMUNOLOGY Paul Duncan is Senior Director, External Innovation for the Immunology Global Commercial Strategy Organization of Janssen Global Services. In this role, Paul is responsible for leading the overall ...
Global Public Health
Global Public Health Global Public Health Nelly Velez, The World Among Us About Our Global Public Health Initiative Global Public Health Research Increasing Sustainable Access to Medicines Our Partnerships Fighting Multi-Drug Resistant Tuberculosis ...
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials What does “innovation” mean to you? We hear it so often in today’s world; it appears as though everyone is innovating. In fact, it would almost seem odd if a core pillar of a ...
Disease Prevention & Interception in Healthcare
Disease Prevention, Disease Interception, and Microbiome Research Platforms Focused on Redefining Healthcare Janssen Research & Development's three new research platforms focus on disease prevention, disease interception, and the microbiome – ...